TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 105 filers reported holding TG THERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is 1.01 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $131,912 | -65.9% | 15,779 | -38.7% | 0.04% | -69.0% |
Q1 2023 | $387,069 | +62.6% | 25,736 | +53.8% | 0.13% | +117.2% |
Q1 2018 | $238,000 | +52.6% | 16,738 | +8.0% | 0.06% | +7.4% |
Q2 2017 | $156,000 | +81.4% | 15,500 | -16.7% | 0.05% | +20.0% |
Q4 2016 | $86,000 | – | 18,600 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RA Capital Management | 8,198,337 | $33,613,000 | 1.96% |
GREAT POINT PARTNERS LLC | 3,000,000 | $12,300,000 | 1.56% |
BRIDGER MANAGEMENT, LLC | 3,791,531 | $15,545,000 | 1.30% |
Avoro Capital Advisors LLC | 4,750,000 | $19,475,000 | 1.16% |
Opaleye Management Inc. | 550,000 | $2,255,000 | 0.84% |
CREDIT AGRICOLE S A | 1,307,428 | $5,360,000 | 0.30% |
Eversept Partners, LP | 65,000 | $266,500 | 0.14% |
HIGHLAND CAPITAL MANAGEMENT LP | 453,360 | $1,859,000 | 0.14% |
683 Capital Management, LLC | 500,000 | $2,050,000 | 0.12% |
Artal Group S.A. | 400,000 | $1,640,000 | 0.06% |